Translate to multiple languages

Subscribe to my Email updates

https://feedburner.google.com/fb/a/mailverify?uri=helgeScherlundelearning
Enjoy what you've read, make sure you subscribe to my Email Updates

Friday, September 25, 2020

Perspecta Labs to conduct critical research for machine learning and artificial intelligence security | Releases - PRNewswire

Perspecta Inc. (NYSE: PRSP), announced today that its innovative applied research arm, Perspecta Labs, received an award from the Intelligence Advanced Research Projects Activity (IARPA) to provide research on the Trojans in Artificial Intelligence (TrojAI) program.

Photo: Perspecta Inc.

Advancements in artificial intelligence (AI) and machine learning (ML) have added complexity to the threat landscape. By hacking the training phase of ML, adversaries can disrupt AI systems during development, causing them to make incorrect classifications and take dangerous actions. The goal of the TrojAI program is to detect adversarial Trojans placed into AI systems to prevent such attacks. Perspecta Labs will lead a team of researchers to study Trojan contamination and develop and provide a multi-faceted detection mechanism to significantly reduce Trojan security risks...

Read more... 

About Perspecta Inc.

At Perspecta (NYSE: PRSP), we question, we seek and we solve. Perspecta brings a diverse set of capabilities to our U.S. government customers in defense, intelligence, civilian, health care and state and local markets. Our 280+ issued, licensed and pending patents are more than just pieces of paper, they tell the story of our innovation. With offerings in mission services, digital transformation and enterprise operations, our team of nearly 14,000 engineers, analysts, investigators and architects work tirelessly to not only execute the mission, but build and support the backbone that enables it. Perspecta was formed to take on big challenges. We are an engine for growth and success and we enable our customers to build a better nation.  

For more information about Perspecta, visit perspecta.com. 

Source: PRNewswire